.png)
CritiTech is a fast-growing CDMO built upon our unique particle engineering expertise and our high-quality on-time project delivery. Our patented Purcision platform enables us to formulate drugs for local targeted delivery, delivering pure drug at higher concentrations and longer durations while reducing systemic exposure. CritiTech's Purcision and Spray Drying capabilities range from Proof of Concept to large GMP projects supporting into Phase III trials and even smaller commercial delivery. Our dedicated cytotoxic and non-cytotoxic facilities and ability to handle highly potent compounds combined with our deep particle engineering expertise and dedication to our customers' goals set us apart from most CDMOs.